Sandip Patel, MD FASCO
@pateloncology.bsky.social
Professor, Medical Oncology @UCSD; Phase 1 & thoracic/NSCLC immunotherapy, solid tumor cell therapy, spatial biology, irAEs, wearables, cancer informatics & AI
Wonder if low grade irAE demonstrates immunostat function with potential for clinical efficacy, while high grade is prohibitive for sufficient dosing for anti-tumor effect
December 1, 2024 at 2:41 AM
Wonder if low grade irAE demonstrates immunostat function with potential for clinical efficacy, while high grade is prohibitive for sufficient dosing for anti-tumor effect
This is great @n8pennell.bsky.social will add as I see folks join
November 13, 2024 at 7:38 PM
This is great @n8pennell.bsky.social will add as I see folks join
Nice to see @najarvg.bsky.social, @morganslevy.bsky.social and so many others over here!
November 13, 2024 at 7:36 PM
Nice to see @najarvg.bsky.social, @morganslevy.bsky.social and so many others over here!